Recursion Pharmaceuticals Aktie News
9,03 $
3,53 %
gestern
Nasdaq,
23. Mai, 22:13 Uhr
tracken
Recursion Pharmaceuticals Aktie News
Neutral
The Motley Fool
●
8 Tage alt
Some high-tech biotechs claim to be "TechBio" companies. The term signals the use of an automation-heavy approach to biotech.
Neutral
GlobeNewsWire
●
11 Tage alt
BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024. BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.
Positiv
The Motley Fool
●
11 Tage alt
Recursion Pharmaceuticals, an AI-focused biotech, makes up more than 5% of one of Ark Invest's ETFs. The company's approach looks promising, but it has yet to produce the kinds of results investors want.
Neutral
Seeking Alpha
●
14 Tage alt
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Chris Gibson - Co-Founder & Chief Executive Officer Conference Call Participants Chris Gibson Hi, everybody. I'm Chris Gibson, Co-Founder and CEO of Recursion, and I'm so delighted you've joined us today for our Q1 2024 Earnings Call -- L(earnings) Call, as we call it.
Neutral
GlobeNewsWire
●
14 Tage alt
SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today reported business updates and financial results for its first quarter ending March 31, 2024.
Neutral
GlobeNewsWire
●
21 Tage alt
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and report its first quarter 2024 financial results on Thursday, May 9, 2024, following the close of the financial markets. Additionally, Recursion will host its quarterly L(earnings...
Neutral
GlobeNewsWire
●
22 Tage alt
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
Positiv
The Motley Fool
●
26 Tage alt
Nvidia's equity portfolio ballooned beyond $100 million in the fourth quarter, requiring public disclosures. Just two stocks make up nearly all of its portfolio.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
